首页 > 最新文献

Basic and applied pathology最新文献

英文 中文
History of reimbursement system for routine histopathology services by the National Health Insurance in Korea 韩国国民健康保险常规组织病理学服务报销制度的历史
Pub Date : 2009-09-02 DOI: 10.1111/j.1755-9294.2009.01051.x
Jeong-Wook Seo, Se Jin Jang, Min Suk Kim, Chang Suk Kang, Woon Sup Han

In January 2009, a new classification of pathology services was been launched for the reimbursement by the National Health Insurance system in Korea. Five basic types of surgical pathology services are reclassified into 13 types and their resource based relative value scores are adjusted. In this report, we summarize the history of the classification system for the reimbursement on pathology services and report the impact of the change in January 2009 on the distribution of cases and contribution on the income of the department of pathology from each class at the Seoul National University Hospital.

2009年1月,韩国启动了一项新的病理服务分类,以供国民健康保险系统报销。将5种基本的外科病理服务重新划分为13种,并对其基于资源的相对价值评分进行调整。在本报告中,我们总结了病理服务报销分类系统的历史,并报告了2009年1月对首尔国立大学医院病理科室每个班级的病例分布和收入贡献的影响。
{"title":"History of reimbursement system for routine histopathology services by the National Health Insurance in Korea","authors":"Jeong-Wook Seo,&nbsp;Se Jin Jang,&nbsp;Min Suk Kim,&nbsp;Chang Suk Kang,&nbsp;Woon Sup Han","doi":"10.1111/j.1755-9294.2009.01051.x","DOIUrl":"10.1111/j.1755-9294.2009.01051.x","url":null,"abstract":"<div>\u0000 \u0000 <p>In January 2009, a new classification of pathology services was been launched for the reimbursement by the National Health Insurance system in Korea. Five basic types of surgical pathology services are reclassified into 13 types and their resource based relative value scores are adjusted. In this report, we summarize the history of the classification system for the reimbursement on pathology services and report the impact of the change in January 2009 on the distribution of cases and contribution on the income of the department of pathology from each class at the Seoul National University Hospital.</p>\u0000 </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 3","pages":"79-81"},"PeriodicalIF":0.0,"publicationDate":"2009-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01051.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63679059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
EBM 循证医学
Pub Date : 2009-09-02 DOI: 10.1111/j.1755-9294.2009.01052.x
{"title":"EBM","authors":"","doi":"10.1111/j.1755-9294.2009.01052.x","DOIUrl":"https://doi.org/10.1111/j.1755-9294.2009.01052.x","url":null,"abstract":"","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 3","pages":"109-110"},"PeriodicalIF":0.0,"publicationDate":"2009-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01052.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137780394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathologic significance of survivin expression in colorectal adenocarcinoma survivin在结直肠腺癌组织表达的临床病理意义
Pub Date : 2009-09-02 DOI: 10.1111/j.1755-9294.2009.01049.x
Woong Na, Se Min Jang, Young Jin Jun, Young Soo Song, Ki-Seok Jang, Kang Hong Lee, Kyeong Geun Lee, Hong Xiu Han, Seung Sam Paik

Background and aim: Survivin, an antiapoptotic protein, is involved in both the control of the cell division and the inhibition of apoptosis. The regulation of apoptotic cell death may have a profound effect on the carcinogenesis and progression of colorectal cancer. This study was designed to evaluate the survivin expression in colorectal tissues and to investigate whether the survivin expression is associated with the clinicopathologic characteristics and the patient survival. Methods: Immunohistochemical analysis of survivin was performed using the tissue microarrays of 622 colorectal tissue samples from 529 colorectal adenocarcinomas, 40 normal mucosa, 34 adenomatous polyps, and 59 metastatic lymph nodes. Results: Normal colorectal mucosa were completely negative for survivin (0/40, 0%), but survivin was expressed in adenomatous polyps (8/34, 23.5%), adenocarcinomas (327/529, 61.8%), and metastatic lymph nodes (27/59, 45.8%). In the analyses between the survivin expression and clinicopathologic parameters, the survivin expression was correlated with tumor location in colon (P= 0.026), lymph node metastasis (P= 0.003) and American Joint Committee on Cancer (AJCC) stage (P= 0.040). The patient survival was significantly associated with age, histologic grade, AJCC stage, and lymphovascular invasion. On stage wise analyses of patient survival, the survivin expression was significantly correlated with overall survival (P < 0.001) and disease free survival (P < 0.001), especially in stage II colorectal adenocarcinomas. Conclusions: The results suggest that the survivin expression is a relatively frequent early event of colorectal carcinogenesis and may play an important role in the adenoma-carcinoma transition sequence. Survivin expression provides important prognostic information and an apoptosis-based therapeutic target in colorectal adenocarcinomas.

背景与目的:Survivin是一种抗凋亡蛋白,既参与细胞分裂的控制,又参与细胞凋亡的抑制。凋亡细胞死亡的调控可能对结直肠癌的发生和发展有深远的影响。本研究旨在评估survivin在结直肠组织中的表达,探讨survivin的表达是否与临床病理特征及患者生存率相关。方法:采用组织芯片对529例结直肠腺癌、40例正常粘膜、34例腺瘤性息肉和59例转移性淋巴结的622例结直肠组织样本进行survivin免疫组化分析。结果:正常结直肠粘膜survivin表达完全阴性(0/ 40,0%),但在腺瘤性息肉(8/ 34,23.5%)、腺癌(327/529,61.8%)和转移性淋巴结(27/ 59,45.8%)中表达survivin。survivin表达与临床病理参数的关系分析显示,survivin表达与肿瘤在结肠的位置(P= 0.026)、淋巴结转移(P= 0.003)和美国癌症联合委员会(AJCC)分期(P= 0.040)相关。患者的生存与年龄、组织学分级、AJCC分期和淋巴血管侵犯显著相关。在患者生存期的分期分析中,survivin的表达与总生存期显著相关(P <0.001)和无病生存率(P <0.001),尤其是II期结直肠癌。结论:survivin的表达是结直肠癌发生早期较为常见的事件,可能在腺瘤-癌转化过程中起重要作用。Survivin的表达在结直肠癌中提供了重要的预后信息和基于凋亡的治疗靶点。
{"title":"Clinicopathologic significance of survivin expression in colorectal adenocarcinoma","authors":"Woong Na,&nbsp;Se Min Jang,&nbsp;Young Jin Jun,&nbsp;Young Soo Song,&nbsp;Ki-Seok Jang,&nbsp;Kang Hong Lee,&nbsp;Kyeong Geun Lee,&nbsp;Hong Xiu Han,&nbsp;Seung Sam Paik","doi":"10.1111/j.1755-9294.2009.01049.x","DOIUrl":"10.1111/j.1755-9294.2009.01049.x","url":null,"abstract":"<div>\u0000 \u0000 <p> <b>Background and aim:</b> Survivin, an antiapoptotic protein, is involved in both the control of the cell division and the inhibition of apoptosis. The regulation of apoptotic cell death may have a profound effect on the carcinogenesis and progression of colorectal cancer. This study was designed to evaluate the survivin expression in colorectal tissues and to investigate whether the survivin expression is associated with the clinicopathologic characteristics and the patient survival. <b>Methods:</b> Immunohistochemical analysis of survivin was performed using the tissue microarrays of 622 colorectal tissue samples from 529 colorectal adenocarcinomas, 40 normal mucosa, 34 adenomatous polyps, and 59 metastatic lymph nodes. <b>Results:</b> Normal colorectal mucosa were completely negative for survivin (0/40, 0%), but survivin was expressed in adenomatous polyps (8/34, 23.5%), adenocarcinomas (327/529, 61.8%), and metastatic lymph nodes (27/59, 45.8%). In the analyses between the survivin expression and clinicopathologic parameters, the survivin expression was correlated with tumor location in colon (<i>P</i>= 0.026), lymph node metastasis (<i>P</i>= 0.003) and American Joint Committee on Cancer (AJCC) stage (<i>P</i>= 0.040). The patient survival was significantly associated with age, histologic grade, AJCC stage, and lymphovascular invasion. On stage wise analyses of patient survival, the survivin expression was significantly correlated with overall survival (<i>P</i> &lt; 0.001) and disease free survival (<i>P</i> &lt; 0.001), especially in stage II colorectal adenocarcinomas. <b>Conclusions:</b> The results suggest that the survivin expression is a relatively frequent early event of colorectal carcinogenesis and may play an important role in the adenoma-carcinoma transition sequence. Survivin expression provides important prognostic information and an apoptosis-based therapeutic target in colorectal adenocarcinomas.</p>\u0000 </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 3","pages":"94-100"},"PeriodicalIF":0.0,"publicationDate":"2009-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01049.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63679335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Fatal pulmonary complications associated with activated charcoal: An autopsy case 与活性炭相关的致命肺部并发症:一个尸检病例
Pub Date : 2009-09-02 DOI: 10.1111/j.1755-9294.2009.01048.x
Sung-Im Do, Sohyung Park, Hongil Ha, Hyoung-Joong Kim

Activated charcoal is commonly used in the treatment of patients experiencing an oral overdose of drugs and is considered to be a safe, inert agent. However, various complications associated with the use of activated charcoal have been reported, with acute respiratory failure being a fatal one. In the presenting case, a 29-year-old female arrived at an emergency room having taken an overdose of drugs. When a nasogastric tube was inserted for gastric lavage and charcoal administration, she vomited and respiration ceased. The patient subsequently developed acute respiratory failure and died 19 days after admission. Charcoal deposition in the trachea, bronchi and lungs was observed on the postmortem examination.

活性炭通常用于治疗口服药物过量的患者,被认为是一种安全的惰性剂。然而,与使用活性炭相关的各种并发症已被报道,急性呼吸衰竭是致命的。在本病例中,一名29岁的女性因服用过量药物而被送往急诊室。当插入鼻胃管进行洗胃和给药时,她呕吐,呼吸停止。患者随后出现急性呼吸衰竭,入院19天后死亡。尸检发现气管、支气管和肺部均有木炭沉积。
{"title":"Fatal pulmonary complications associated with activated charcoal: An autopsy case","authors":"Sung-Im Do,&nbsp;Sohyung Park,&nbsp;Hongil Ha,&nbsp;Hyoung-Joong Kim","doi":"10.1111/j.1755-9294.2009.01048.x","DOIUrl":"10.1111/j.1755-9294.2009.01048.x","url":null,"abstract":"<div>\u0000 \u0000 <p>Activated charcoal is commonly used in the treatment of patients experiencing an oral overdose of drugs and is considered to be a safe, inert agent. However, various complications associated with the use of activated charcoal have been reported, with acute respiratory failure being a fatal one. In the presenting case, a 29-year-old female arrived at an emergency room having taken an overdose of drugs. When a nasogastric tube was inserted for gastric lavage and charcoal administration, she vomited and respiration ceased. The patient subsequently developed acute respiratory failure and died 19 days after admission. Charcoal deposition in the trachea, bronchi and lungs was observed on the postmortem examination.</p>\u0000 </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 3","pages":"106-108"},"PeriodicalIF":0.0,"publicationDate":"2009-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01048.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63679281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Significance of Wip1 overexpression in breast cancer: Strong association with hormone receptor expression and nodal metastasis Wip1过表达在乳腺癌中的意义:与激素受体表达和淋巴结转移密切相关
Pub Date : 2009-09-02 DOI: 10.1111/j.1755-9294.2009.01047.x
Jene Choi, Mi-Jung Kim, Hye-Sook Han, Gyungyub Gong, Eunsil Yu

Background and aim: Wild-type p53-induced phosphatase (Wip1), a serine/threonine phosphatase encoded by Ppm1d, is a protein, induced by p53 in response to DNA damage. Recently, correlation between Ppm1d amplification and erbB2 expression has been reported in breast cancers. However, in vitro experiments provide evidences suggesting a relationship between Wip1 and hormone receptor (HR) activity. The aim of the current study was to clarify the relationship between Wip1 overexpression and the expression of HR and erbB2, and to investigate the prognostic significance of Wip1 in breast cancer. Methods: Using tissue microarrays that contained 743 cases of primary invasive breast cancers, we analyzed Ppm1d copy number and examined the expression of Wip1, HRs, p53 and erbB2 by immunohistochemistry. Results:Ppm1d was amplified in 4.7% of breast cancer tumors, while Wip1 was overexpressed in 20.8%. Wip1 overexpression was associated with low nuclear grade (P= 0.032), higher expression of progesterone receptor (P= 0.001), and increased nodal metastasis (P= 0.013). No statistically significant correlations were identified among other clinicopathologic parameters. Conclusions: The close correlation between Wip1 overexpression, progesterone receptor expression and nodal metastasis suggest that Wip1 expression is closely associated with HR activity and might heighten the malignant properties of breast cancers through hormone-mediated tumor growth and progression.

背景与目的:野生型p53诱导磷酸酶(Wip1)是一种由Ppm1d编码的丝氨酸/苏氨酸磷酸酶,是p53在DNA损伤时诱导的一种蛋白。最近,Ppm1d扩增和erbB2表达在乳腺癌中有相关报道。然而,体外实验提供证据表明Wip1与激素受体(HR)活性之间存在关系。本研究旨在阐明Wip1过表达与HR、erbB2表达的关系,探讨Wip1在乳腺癌中的预后意义。方法:采用组织芯片技术分析743例原发性浸润性乳腺癌组织中Ppm1d拷贝数,免疫组化检测Wip1、hr、p53、erbB2的表达。结果:Ppm1d在4.7%的乳腺癌肿瘤中扩增,而Wip1在20.8%的乳腺癌肿瘤中过表达。Wip1过表达与低核分级(P= 0.032)、孕酮受体高表达(P= 0.001)和淋巴结转移增加(P= 0.013)相关。其他临床病理参数之间无统计学意义的相关性。结论:Wip1过表达、孕酮受体表达与淋巴结转移密切相关,提示Wip1表达与HR活性密切相关,并可能通过激素介导的肿瘤生长和进展增强乳腺癌的恶性特性。
{"title":"Significance of Wip1 overexpression in breast cancer: Strong association with hormone receptor expression and nodal metastasis","authors":"Jene Choi,&nbsp;Mi-Jung Kim,&nbsp;Hye-Sook Han,&nbsp;Gyungyub Gong,&nbsp;Eunsil Yu","doi":"10.1111/j.1755-9294.2009.01047.x","DOIUrl":"10.1111/j.1755-9294.2009.01047.x","url":null,"abstract":"<div>\u0000 \u0000 <p> <b>Background and aim:</b> Wild-type p53-induced phosphatase (Wip1), a serine/threonine phosphatase encoded by <i>Ppm1d</i>, is a protein, induced by p53 in response to DNA damage. Recently, correlation between Ppm1d amplification and erbB2 expression has been reported in breast cancers. However, <i>in vitro</i> experiments provide evidences suggesting a relationship between Wip1 and hormone receptor (HR) activity. The aim of the current study was to clarify the relationship between Wip1 overexpression and the expression of HR and erbB2, and to investigate the prognostic significance of Wip1 in breast cancer. <b>Methods:</b> Using tissue microarrays that contained 743 cases of primary invasive breast cancers, we analyzed <i>Ppm1d</i> copy number and examined the expression of Wip1, HRs, p53 and erbB2 by immunohistochemistry. <b>Results:</b><i>Ppm1d</i> was amplified in 4.7% of breast cancer tumors, while Wip1 was overexpressed in 20.8%. Wip1 overexpression was associated with low nuclear grade (<i>P</i>= 0.032), higher expression of progesterone receptor (<i>P</i>= 0.001), and increased nodal metastasis (<i>P</i>= 0.013). No statistically significant correlations were identified among other clinicopathologic parameters. <b>Conclusions:</b> The close correlation between Wip1 overexpression, progesterone receptor expression and nodal metastasis suggest that Wip1 expression is closely associated with HR activity and might heighten the malignant properties of breast cancers through hormone-mediated tumor growth and progression.</p>\u0000 </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 3","pages":"89-93"},"PeriodicalIF":0.0,"publicationDate":"2009-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01047.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63679227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Genetic mutation of transforming growth factor beta type II receptor in oral squamous cell carcinoma 口腔鳞状细胞癌中转化生长因子β II型受体的基因突变
Pub Date : 2009-09-02 DOI: 10.1111/j.1755-9294.2009.01046.x
Eun Ha Lee, Kyung Jin Bae, Tae Kyu Kim, Hye-Seo Park, Eun Ju Lee, Jin Kim

Background and aim: The deregulation of transforming growth factor β (TGF-β) action and its signaling function has been a widely accepted concept in carcinogenesis. However, its dual roles, as a tumor suppressor gene and oncogene, have interfered in applying TGF-β signaling to cancer therapeutics. To evaluate its role in the carcinogenesis of oral squamous cell carcinoma (OSCC), we performed mutational analysis of the TGF-β type II receptor (TβRII). Methods: Eighteen cases of OSCC were used for mutational analysis of TβRII. Normal surgical margin, dysplastic lesion, invasive carcinoma and metastatic cancer cells into lymph node tissue were used. Exon-specific spanning primers of exon 1, 2, 3, 4, 5, 6, 7 of TβRII were used for the mutational analysis. Results: A single nucleotide polymorphism (SNP) at the codon 191 was found in 8 cases. The genetic mutations were mainly found in exon 4 through dysplastic areas, carcinoma and metastatic areas, which induced the structural change or the alteration of hydrophobicity of the amino acid. Conclusions:TβRII mutations occur frequently in exon 4 in OSCC and their functional significance should be proven.

背景与目的:TGF-β (transforming growth factor β, TGF-β)作用及其信号转导功能的调控在癌变过程中已被广泛接受。然而,其作为肿瘤抑制基因和癌基因的双重作用干扰了TGF-β信号在癌症治疗中的应用。为了评估其在口腔鳞状细胞癌(OSCC)癌变中的作用,我们对TGF-β II型受体(t -β rii)进行了突变分析。方法:对18例OSCC患者进行TβRII基因突变分析。正常手术切缘、发育不良病变、浸润性癌和转移性淋巴结组织癌细胞。利用TβRII外显子1、2、3、4、5、6、7的外显子特异性跨越引物进行突变分析。结果:8例患者在191密码子处发现单核苷酸多态性(SNP)。基因突变主要发生在4外显子,通过发育不良区、癌区和转移区,引起氨基酸结构改变或疏水性改变。结论:TβRII突变多发于OSCC外显子4,其功能意义有待证实。
{"title":"Genetic mutation of transforming growth factor beta type II receptor in oral squamous cell carcinoma","authors":"Eun Ha Lee,&nbsp;Kyung Jin Bae,&nbsp;Tae Kyu Kim,&nbsp;Hye-Seo Park,&nbsp;Eun Ju Lee,&nbsp;Jin Kim","doi":"10.1111/j.1755-9294.2009.01046.x","DOIUrl":"10.1111/j.1755-9294.2009.01046.x","url":null,"abstract":"<div>\u0000 \u0000 <p> <b>Background and aim:</b> The deregulation of transforming growth factor β (<i>TGF-β</i>) action and its signaling function has been a widely accepted concept in carcinogenesis. However, its dual roles, as a tumor suppressor gene and oncogene, have interfered in applying <i>TGF-β</i> signaling to cancer therapeutics. To evaluate its role in the carcinogenesis of oral squamous cell carcinoma (OSCC), we performed mutational analysis of the <i>TGF-β</i> type II receptor (<i>TβRII</i>). <b>Methods:</b> Eighteen cases of OSCC were used for mutational analysis of <i>TβRII</i>. Normal surgical margin, dysplastic lesion, invasive carcinoma and metastatic cancer cells into lymph node tissue were used. Exon-specific spanning primers of exon 1, 2, 3, 4, 5, 6, 7 of <i>TβRII</i> were used for the mutational analysis. <b>Results:</b> A single nucleotide polymorphism (SNP) at the codon 191 was found in 8 cases. The genetic mutations were mainly found in exon 4 through dysplastic areas, carcinoma and metastatic areas, which induced the structural change or the alteration of hydrophobicity of the amino acid. <b>Conclusions:</b><i>TβRII</i> mutations occur frequently in exon 4 in OSCC and their functional significance should be proven.</p>\u0000 </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 3","pages":"82-88"},"PeriodicalIF":0.0,"publicationDate":"2009-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01046.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63679211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
p53 gene mutation and COX-2 expression in hepatocellular carcinoma 肝癌中p53基因突变与COX-2表达的关系
Pub Date : 2009-05-29 DOI: 10.1111/j.1755-9294.2009.01043.x
Moon-Il Park, Song-Yi Choi, Sun-Young Na, Dae Young Kang

Backgroud and aim: We investigated the incidence of codon 249 mutation of p53 in hepatocelluar carcinoma (HCC) and the relation between cyclooxygenase-2 (COX-2) expression in HCC and survival of the patients. Methods: Forty-one cases of HCC from 1988 to 2007 were retrieved from the files of department of pathology, Chungnam National University Hospital. We performed single strand confirmation polymorphism (SSCP) and direct DNA sequencing for detection of p53 mutation and immunohistochemical staining using monoclonal antibody to COX-2. Results: SSCP and direct DNA sequencing revealed a p53 mutation at exon 7 in one of 41 cases (2.4%). The mutation was observed at codon 249 and consisted of a G–T transversion in the third position of this codon, resulting in an amino acid change from arginine to serine (missense mutation). Positive COX-2 staining (score ≥ 100) was observed in thirty-three of 41 cases (80.5%) and high score (score ≥ 200) in 15 of 41 (36.6%). The high-score group showed a worse survival than the low-score group (score < 200) in Fisher's exact test with confidence level at 90%. Conclusion: This is the first report on the existence of p53 codon 249 mutation of HCC in Korea.

背景与目的:探讨肝癌(HCC)中p53密码子249突变的发生率及环氧化酶-2 (COX-2)在HCC中的表达与患者生存率的关系。方法:从1988 ~ 2007年忠南大学附属医院病理科资料中检索41例肝癌病例。我们使用单链确认多态性(SSCP)和直接DNA测序检测p53突变,并使用COX-2单克隆抗体进行免疫组化染色。结果:SSCP和直接DNA测序显示41例患者中有1例(2.4%)外显子7处p53突变。该突变发生在密码子249上,该密码子第三位发生G-T翻转,导致氨基酸从精氨酸变为丝氨酸(错义突变)。41例患者中COX-2阳性(评分≥100)33例(80.5%),高评分(评分≥200)15例(36.6%)。得分高的组生存率低于得分低的组(得分<200)在Fisher精确检验中,置信水平为90%。结论:国内首次报道HCC存在p53密码子249突变。
{"title":"p53 gene mutation and COX-2 expression in hepatocellular carcinoma","authors":"Moon-Il Park,&nbsp;Song-Yi Choi,&nbsp;Sun-Young Na,&nbsp;Dae Young Kang","doi":"10.1111/j.1755-9294.2009.01043.x","DOIUrl":"10.1111/j.1755-9294.2009.01043.x","url":null,"abstract":"<div>\u0000 \u0000 <p> <b>Backgroud and aim:</b> We investigated the incidence of codon 249 mutation of p53 in hepatocelluar carcinoma (HCC) and the relation between cyclooxygenase-2 (COX-2) expression in HCC and survival of the patients. <b>Methods:</b> Forty-one cases of HCC from 1988 to 2007 were retrieved from the files of department of pathology, Chungnam National University Hospital. We performed single strand confirmation polymorphism (SSCP) and direct DNA sequencing for detection of p53 mutation and immunohistochemical staining using monoclonal antibody to COX-2. <b>Results:</b> SSCP and direct DNA sequencing revealed a p53 mutation at exon 7 in one of 41 cases (2.4%). The mutation was observed at codon 249 and consisted of a G–T transversion in the third position of this codon, resulting in an amino acid change from arginine to serine (missense mutation). Positive COX-2 staining (score ≥ 100) was observed in thirty-three of 41 cases (80.5%) and high score (score ≥ 200) in 15 of 41 (36.6%). The high-score group showed a worse survival than the low-score group (score &lt; 200) in Fisher's exact test with confidence level at 90%. <b>Conclusion:</b> This is the first report on the existence of p53 codon 249 mutation of HCC in Korea.</p>\u0000 </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 2","pages":"47-52"},"PeriodicalIF":0.0,"publicationDate":"2009-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01043.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63679150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Diagnostic value of decreased expression of CD56 protein in papillary carcinoma of the thyroid gland CD56蛋白表达降低在甲状腺乳头状癌中的诊断价值
Pub Date : 2009-05-29 DOI: 10.1111/j.1755-9294.2009.01045.x
Won Young Park, Seong Muk Jeong, Jung Hee Lee, Hyun Jeong Kang, Dong Hun Sin, Kyung Un Choi, Do Youn Park, Gi Yeong Huh, Mee Young Sol, Chang Hun Lee

Background and aims: Precise pathological diagnosis is essential for optimal treatment of thyroid tumors. Ancillary diagnostic markers may be helpful in some cases. The purpose of this study was to compare and evaluate the diagnostic value of CD56, cytokeratin 19 (CK19), and galectin-3 immunohistochemical stainings in distinguishing between papillary carcinoma (PC) and other thyroid malignancies and benign lesions. Methods: The expressions of the three markers were evaluated in PC (n= 67), follicular carcinoma (FC, n= 23), medullary carcinoma (MC, n= 18), anaplastic carcinoma (AC, n= 4), follicular adenoma (FA, n= 15), and nodular hyperplasia (NH, n= 21). Results: Statistical analysis showed significantly different expressions of CD56, galectin-3, and CK19 in PC versus other lesions of the thyroid gland, with the exception of AC. Especially, the sensitivity and specificity of CD56 for diagnosing PC were 92.5% and 86.4%, respectively. The diagnostic specificity of CD56 was higher than that of galectin-3 or CK19 in differentiating PC from other lesions of the thyroid gland. However, its sensitivity was lower than that of galectin-3 or CK19. Conclusion: CD56 turns out to be a good negative marker for diagnosing PC. We suggest that immunohistochemical panels directed at the diagnosis of PC should include CD56 together with galectin-3 and CK19.

背景与目的:准确的病理诊断对甲状腺肿瘤的最佳治疗至关重要。辅助诊断标记在某些情况下可能会有所帮助。本研究的目的是比较和评价CD56、细胞角蛋白19 (CK19)和半乳糖凝集素-3免疫组化染色在鉴别乳头状癌(PC)及其他甲状腺恶性病变和良性病变中的诊断价值。方法:分别在PC(67例)、滤泡性癌(FC, 23例)、髓样癌(MC, 18例)、间变性癌(AC, 4例)、滤泡性腺瘤(FA, 15例)、结节性增生(NH, 21例)中检测3种标志物的表达。结果:统计分析显示,除AC外,CD56、半凝集素-3、CK19在PC中的表达与甲状腺其他病变有显著差异,其中CD56诊断PC的敏感性为92.5%,特异性为86.4%。CD56在鉴别PC与甲状腺其他病变方面的诊断特异性高于半凝集素-3或CK19。但其敏感性低于半乳糖凝集素-3和CK19。结论:CD56是诊断PC的良好阴性标志物。我们建议用于PC诊断的免疫组化面板应包括CD56、半乳糖凝集素-3和CK19。
{"title":"Diagnostic value of decreased expression of CD56 protein in papillary carcinoma of the thyroid gland","authors":"Won Young Park,&nbsp;Seong Muk Jeong,&nbsp;Jung Hee Lee,&nbsp;Hyun Jeong Kang,&nbsp;Dong Hun Sin,&nbsp;Kyung Un Choi,&nbsp;Do Youn Park,&nbsp;Gi Yeong Huh,&nbsp;Mee Young Sol,&nbsp;Chang Hun Lee","doi":"10.1111/j.1755-9294.2009.01045.x","DOIUrl":"10.1111/j.1755-9294.2009.01045.x","url":null,"abstract":"<div>\u0000 \u0000 <p> <b>Background and aims:</b> Precise pathological diagnosis is essential for optimal treatment of thyroid tumors. Ancillary diagnostic markers may be helpful in some cases. The purpose of this study was to compare and evaluate the diagnostic value of CD56, cytokeratin 19 (CK19), and galectin-3 immunohistochemical stainings in distinguishing between papillary carcinoma (PC) and other thyroid malignancies and benign lesions. <b>Methods:</b> The expressions of the three markers were evaluated in PC (<i>n</i>= 67), follicular carcinoma (FC, <i>n</i>= 23), medullary carcinoma (MC, <i>n</i>= 18), anaplastic carcinoma (AC, <i>n</i>= 4), follicular adenoma (FA, <i>n</i>= 15), and nodular hyperplasia (NH, <i>n</i>= 21). <b>Results:</b> Statistical analysis showed significantly different expressions of CD56, galectin-3, and CK19 in PC versus other lesions of the thyroid gland, with the exception of AC. Especially, the sensitivity and specificity of CD56 for diagnosing PC were 92.5% and 86.4%, respectively. The diagnostic specificity of CD56 was higher than that of galectin-3 or CK19 in differentiating PC from other lesions of the thyroid gland. However, its sensitivity was lower than that of galectin-3 or CK19. <b>Conclusion</b>: CD56 turns out to be a good negative marker for diagnosing PC. We suggest that immunohistochemical panels directed at the diagnosis of PC should include CD56 together with galectin-3 and CK19.</p>\u0000 </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 2","pages":"63-68"},"PeriodicalIF":0.0,"publicationDate":"2009-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01045.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63679160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 29
Sclerosing hemangioma with multifocal pulmonary neuroendocrine cell hyperplasia and tumorlets 硬化性血管瘤伴多灶性肺神经内分泌细胞增生及小肿瘤
Pub Date : 2009-05-29 DOI: 10.1111/j.1755-9294.2009.01042.x
Hyun-Soo Kim, Ahrim Moon, Gou Young Kim, Sung-Jig Lim

Sclerosing hemangioma (SH) of the lung is a rare primary pulmonary neoplasm and is thought to be benign. Although SH was originally considered to be a variant of a hemangioma and was suggested to be of mesenchymal, mesothelial, endothelial, and neuroendocrine origin, there is now consensus that SH is derived from primitive respiratory epithelium. Pulmonary neuroendocrine cell (PNEC) hyperplasia is considered to be a reactive process associated with regeneration of chronically injured airways or alveoli, such as in lung abscesses, bronchiectasis, cystic fibrosis, and chronic obstructive pulmonary disease. We report a rare case of SH combined with PNEC hyperplasia and tumorlets in a 62-year-old woman. Further studies on the relationship between the histogenesis of SH and PNEC hyperplasia or tumorlets are needed.

肺硬化性血管瘤(SH)是一种罕见的原发性肺肿瘤,被认为是良性的。虽然SH最初被认为是血管瘤的一种变体,并被认为起源于间质、间皮、内皮和神经内分泌,但现在人们一致认为SH起源于原始呼吸道上皮。肺神经内分泌细胞(PNEC)增生被认为是与慢性损伤气道或肺泡再生相关的反应性过程,如肺脓肿、支气管扩张、囊性纤维化和慢性阻塞性肺疾病。我们报告一例罕见的SH合并PNEC增生和肿瘤的62岁妇女。SH的组织发生与PNEC增生或肿瘤之间的关系有待进一步研究。
{"title":"Sclerosing hemangioma with multifocal pulmonary neuroendocrine cell hyperplasia and tumorlets","authors":"Hyun-Soo Kim,&nbsp;Ahrim Moon,&nbsp;Gou Young Kim,&nbsp;Sung-Jig Lim","doi":"10.1111/j.1755-9294.2009.01042.x","DOIUrl":"10.1111/j.1755-9294.2009.01042.x","url":null,"abstract":"<div>\u0000 \u0000 <p>Sclerosing hemangioma (SH) of the lung is a rare primary pulmonary neoplasm and is thought to be benign. Although SH was originally considered to be a variant of a hemangioma and was suggested to be of mesenchymal, mesothelial, endothelial, and neuroendocrine origin, there is now consensus that SH is derived from primitive respiratory epithelium. Pulmonary neuroendocrine cell (PNEC) hyperplasia is considered to be a reactive process associated with regeneration of chronically injured airways or alveoli, such as in lung abscesses, bronchiectasis, cystic fibrosis, and chronic obstructive pulmonary disease. We report a rare case of SH combined with PNEC hyperplasia and tumorlets in a 62-year-old woman. Further studies on the relationship between the histogenesis of SH and PNEC hyperplasia or tumorlets are needed.</p>\u0000 </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 2","pages":"75-78"},"PeriodicalIF":0.0,"publicationDate":"2009-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01042.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63679142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Rare association of Parvovirus B19 infection in Kikuchi's lymphadenitis in Korea 细小病毒B19感染在韩国菊池淋巴结炎的罕见关联
Pub Date : 2009-05-29 DOI: 10.1111/j.1755-9294.2009.01040.x
Bongkyung Shin, Jung Woo Choi, Insun Kim

Background and aims: To determine the role of parvovirus B19 (PVB19) in Kikuchi's lymphadenitis of Korean patients. Methods: We detected PVB19 DNA by polymerase chain reaction, and confirmed by DNA sequencing, and immunohistochemical stain in 67 histologically confirmed cases. Results: Male to female ratio was 1:3 and the mean age was 24.6 years. The cases were classified into proliferative type (60.8%), necrotizing type (33.3%), and xanthomatous type (5.7%) and the duration of the disease was well correlated with progression from proliferative, necrotizing and xanthomatous types. PVB19 was detected in only one patient, who was a 33-year old woman and did not show any specific clinicopathologic characteristics from other patients. Conclusions: Although parvovirus may not play an important role in Kikuchi's lymphadenitis in Korean patients, PVB19 may be still considered one of the agents, relating with Kikuchi's lymphadenitis in Korea. In contrast to the previous studies, we concluded that the association of PVB19 in Kikuchi's lymphadenitis may be an incidental finding rather than a constant features of this disease.

背景与目的:探讨细小病毒B19 (PVB19)在韩国菊地淋巴结炎中的作用。方法:采用聚合酶链反应法检测PVB19 DNA,并对67例组织学确诊病例进行DNA测序和免疫组化染色。结果:男女比例为1:3,平均年龄24.6岁。病例分为增生性(60.8%)、坏死性(33.3%)和黄瘤型(5.7%),病程与增生性、坏死性和黄瘤型进展密切相关。PVB19仅在1例患者中检测到,该患者为33岁女性,未表现出与其他患者不同的任何特定临床病理特征。结论:虽然细小病毒在韩国菊池淋巴结炎患者中可能不起重要作用,但PVB19可能仍被认为是与韩国菊池淋巴结炎有关的病原体之一。与先前的研究相反,我们得出结论,PVB19与菊池淋巴结炎的关联可能是偶然发现,而不是该疾病的恒定特征。
{"title":"Rare association of Parvovirus B19 infection in Kikuchi's lymphadenitis in Korea","authors":"Bongkyung Shin,&nbsp;Jung Woo Choi,&nbsp;Insun Kim","doi":"10.1111/j.1755-9294.2009.01040.x","DOIUrl":"10.1111/j.1755-9294.2009.01040.x","url":null,"abstract":"<div>\u0000 \u0000 <p> <b>Background and aims:</b> To determine the role of parvovirus B19 (PVB19) in Kikuchi's lymphadenitis of Korean patients. <b>Methods:</b> We detected PVB19 DNA by polymerase chain reaction, and confirmed by DNA sequencing, and immunohistochemical stain in 67 histologically confirmed cases. <b>Results:</b> Male to female ratio was 1:3 and the mean age was 24.6 years. The cases were classified into proliferative type (60.8%), necrotizing type (33.3%), and xanthomatous type (5.7%) and the duration of the disease was well correlated with progression from proliferative, necrotizing and xanthomatous types. PVB19 was detected in only one patient, who was a 33-year old woman and did not show any specific clinicopathologic characteristics from other patients. <b>Conclusions:</b> Although parvovirus may not play an important role in Kikuchi's lymphadenitis in Korean patients, PVB19 may be still considered one of the agents, relating with Kikuchi's lymphadenitis in Korea. In contrast to the previous studies, we concluded that the association of PVB19 in Kikuchi's lymphadenitis may be an incidental finding rather than a constant features of this disease.</p>\u0000 </div>","PeriodicalId":92990,"journal":{"name":"Basic and applied pathology","volume":"2 2","pages":"59-62"},"PeriodicalIF":0.0,"publicationDate":"2009-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1755-9294.2009.01040.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"63679085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Basic and applied pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1